Dergiler / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 3

MiR-9 promotes the phenotypic switch of vascular smooth muscle cells by targeting KLF5

Sayfa
928–938
Yayın Tarihi
2022-11-04
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The proliferation and migration of SMCs were reduced bythe miR-9 mimic.Conclusion: miR-9 inhibits the proliferation and migration of SMC by targeting KLF5 in db/db mice.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Diabetic vascular smooth muscle cells (VSMCs) are characterized by increased proliferation and migration.
📊
Temel Bulgular & Veri:However, microRNA in high glucose-induced proinflammation and its atherogenic effect is still ambiguous.Materials and methods: The technique of qRT-PCR was used to examine the expression of miR-9 in VSMCs.
💡
Sonuç & Katkı:The proliferation and migration of SMCs were reduced bythe miR-9 mimic.Conclusion: miR-9 inhibits the proliferation and migration of SMC by targeting KLF5 in db/db mice.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Diabetic vascular smooth muscle cells (VSMCs) are characterized by increased proliferation and migration. Smallnoncoding microRNAs (miRNAs) have been considered critical modulators of the VSMC phenotypic switch after an environmentalstimulus. However, microRNA in high glucose-induced proinflammation and its atherogenic effect is still ambiguous.Materials and methods: The technique of qRT-PCR was used to examine the expression of miR-9 in VSMCs. The downstream signalingprotein relative to miR-9 regulation, Krüppel-like factor 5, and some marker genes of contractile VSMCs were analyzed by westernblotting and qRT-PCR. Luciferase reporter assay was used to detect the expression of KLF5, which is regulated by miR-9. To examinethe function of a miR-9 inhibitor in VSMC proliferation and migration, VSMC proliferation and migration assays were performed.Results: Reduced transcriptional levels of miR-9 and expression of specific genes of contractile VSMCs were observed in the SMC cellline C-12511 treated with high glucose and SMCs, which were isolated from db/db mice. Moreover, the activity of KLF5 3′-UTR wasdramatically reduced by a miR-9 mimic and increased by a miR-9 inhibitor. The proliferation and migration of SMCs were reduced bythe miR-9 mimic.Conclusion: miR-9 inhibits the proliferation and migration of SMC by targeting KLF5 in db/db mice.

🔖

Bu Makaleye Atıf Yap

LI, T., LU, X., MA, S., ZHOU, B. (2022). MiR-9 promotes the phenotypic switch of vascular smooth muscle cells by targeting KLF5. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 3, 928–938. https://ajindex.com/articles/609916

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Lachin JM, Orchard TJ, Nathan DM, Group DER. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 2014; 37: 39-43
  2. Johnson JL. Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis. Cardiovasc Res 2014; 103: 452-460
  3. Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res 2016; 118: 692-702
  4. Li T, Yang GM, Zhu Y, Wu Y, Chen XY, Lan D, Tian KL, Liu LM. Diabetes and hyperlipidemia induce dysfunction of VSMCs: contribution of the metabolic inflammation/miRNA pathway. Am J Physiol Endocrinol Metab 2015; 308: E257-E269
  5. Verspohl EJ, Hagemann J, Lempka M. Vascular smooth muscle cells (VSMC) proliferation of streptozotocin-diabetic animals induced by diadenosine polyphosphates. Exp Clin Endocrinol Diabetes 2004; 112: 142-147
  6. Zhang MJ, Zhou Y, Chen L, Wang YQ, Wang X, Pi Y, Gao CY, Li JC, Zhang LL. An overview of potential molecular mechanisms involved in VSMC phenotypic modulation. Histochem Cell Biol 2016; 145: 119-130
  7. Farrugia MK, Vanderbilt DB, Salkeni MA, Ruppert JM. Kruppel-like pluripotency factors as modulators of cancer cell therapeutic responses. Cancer Res 2016; 76: 1677-1682
  8. Ghaleb AM, Nandan MO, Chanchevalap S, Dalton WB, Hisamuddin IM, Yang VW. Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 2005; 15: 92-96
  9. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009; 105: 158-166
  10. Ha JM, Yun SJ, Jin SY, Lee HS, Kim SJ, Shin HK, Bae SS. Regulation of vascular smooth muscle phenotype by crossregulation of Kruppel-like factors. Korean J Physiol Pharmacol 2017; 21: 37-44
  11. Liu JY, Lu JB, Xu Y. MicroRNA-153 inhibits the proliferation and invasion of human laryngeal squamous cell carcinoma by targeting KLF5. Exp Ther Med 2016; 11: 2503-2508
  12. Li P, Zhu N, Yi B, Wang N, Chen M, You X, Zhao X, Solomides CC, Qin Y, Sun J. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Circ Res 2013; 113: 1117-1127
  13. Tan J, Yang L, Liu C, Yan Z. MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia. Sci Rep 20